For example, atrogin-1 inhibited pathologic cardiac hypertrophy by initiating the degradation of calcineurin, a calcium-dependent phosphatase implicated in pathologic hypertrophy [24]. This evidence concerns the gene FBXO32 and cardiac hypertrophy.